Skip to content

Kimberly Manhard, Director at Inhibrx Biosciences, sold INBX on Sep 9, 2026

Data as of Oct 16

▼ SELL$57.9K500 shares at $115.80Kimberly Manhard DirectorINBX Inhibrx Biosciences, Inc.
Watch INBX
Traded
Sep 9, 2026
Disclosed
Sep 10, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kimberly Manhard, Director at Inhibrx Biosciences, sold INBX on Sep 9, 2026TRADEDDISCLOSED
INBXSimilar stocks (XLV — its sector index fund), rebased to INBX's price on the disclosure day
INBX since disclosure
−19.4%
after the sale
Similar stocks (XLV) since disclosure
+6.7%
XLV — its sector index fund

Change in closing price from Sep 10, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKimberly Manhard DirectorINBX Inhibrx Biosciences, Inc.$57.6Kdisclosed Sep 10 · filed 2 days after the trade

See every trade on INBX →